SCHEMBL5607291

SCHEMBL5607291

CCCC(=Cc1ccc(OCc2ccccc2)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.57
KDM4E B2RXH2 2/20 0.47
MAPT P10636 2/20 0.47
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
NPC1 O15118 1/20 0.47
GAA P10253 1/20 0.47
RAB9A P51151 1/20 0.47
GSK3B P49841 3/20 0.47
BACE1 P56817 3/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
LTA4H P09960 1/20 0.45
MAOB P27338 2/20 0.45
FFAR1 O14842 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
NR4A1 P22736 1/20 0.44
NR4A2 P43354 1/20 0.44
NR4A3 Q92570 1/20 0.44
HDAC3 O15379 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5606696 0.93 NR1H4 (0.55) NR1H4KDM4EMAPTPPARGPPARA
SCHEMBL5607136 0.91 NR1H4 (0.59) NR1H4KDM4EMAPTPPARGPPARA
SCHEMBL5607636 0.87 NR1H4 (0.60) NR1H4KDM4EMAPTNPC1GAA
SCHEMBL5607445 0.86 NR1H4 (0.73) NR1H4KDM4EMAPTNPC1GAA
SCHEMBL5607217 0.85 NR1H4 (0.61) NR1H4KDM4EMAPTNPC1GAA
SCHEMBL5606973 0.84 NR1H4 (0.60) NR1H4KDM4EMAPTPPARGNPC1
SCHEMBL5606740 0.83 NR1H4 (0.58) NR1H4KDM4EMAPTPPARGPPARA
SCHEMBL5607288 0.82 NR1H4 (0.58) NR1H4KDM4EMAPTPPARGPPARA
SCHEMBL5607287 0.82 NR1H4 (0.58) NR1H4KDM4EMAPTPPARGPPARA
SCHEMBL5607131 0.81 NR1H4 (0.67) NR1H4KDM4EMAPTPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR NR1H4 220/4885KDM4E 3298/4885MAPT 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.